1. Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma. (7th May 2021) Authors: Liu, Z; Mi, F; Han, M; Tian, M; Deng, L; Meng, N; Luo, J; Fu, R Journal: Clinical and experimental immunology Issue: Volume 205:Number 1(2021) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗